These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 5995068)

  • 61. [Change of the blood coagulation process under the action of valerian].
    Mirnov VN
    Farmakol Toksikol; 1966; 29(2):187-8. PubMed ID: 6000343
    [No Abstract]   [Full Text] [Related]  

  • 62. The effects of monomethylhydrazine on the coagulation mechanism.SAM-TR-67-64.
    Bairrington JD
    Tech Rep SAM-TR; 1967 Jul; ():1-6. PubMed ID: 5301198
    [No Abstract]   [Full Text] [Related]  

  • 63. [Blood coagulation in dogs following a 1st and second injection of adrenocorticotropin].
    Khubetsova RD; Khetagurova LG
    Probl Endokrinol (Mosk); 1971; 17(3):85-9. PubMed ID: 4333090
    [No Abstract]   [Full Text] [Related]  

  • 64. A comparison of pentosan polysulphate (SP54) and heparin. I: Mechanism of action on blood coagulation.
    Fischer AM; Barrowcliffe TW; Thomas DP
    Thromb Haemost; 1982 Apr; 47(2):104-8. PubMed ID: 6179182
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [To the mechanism of development of adrenaline induced hypercoagulation].
    Kuznik BI; Mishchenko VP
    Farmakol Toksikol; 1967; 30(4):463-7. PubMed ID: 5598903
    [No Abstract]   [Full Text] [Related]  

  • 66. The role of heparin in intrinsic blood coagulation.
    Pitlick FA; Lundblad RL; Davie EW
    J Biomed Mater Res; 1969 Mar; 3(1):95-106. PubMed ID: 5784970
    [No Abstract]   [Full Text] [Related]  

  • 67. [Effect of daphnin on blood coagulation].
    Lakin KM; Kosheleva LI
    Farmakol Toksikol; 1968; 31(1):72-4. PubMed ID: 5675354
    [No Abstract]   [Full Text] [Related]  

  • 68. Studies on blood clotting factors in man after massive liver resection.
    Niléhn JE; Nilsson IM; Aronsen KF; Ericsson B
    Acta Chir Scand; 1967; 133(3):189-95. PubMed ID: 6030166
    [No Abstract]   [Full Text] [Related]  

  • 69. [Importance of PPSB fraction in the treatment of hemophilia A with antibodies against factor VIII].
    Hrubisková K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(4):672-82. PubMed ID: 6162735
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Proteases from Lonomia obliqua venomous secretions: comparison of procoagulant, fibrin(ogen)olytic and amidolytic activities.
    Pinto AF; Silva KR; Guimarães JA
    Toxicon; 2006 Jan; 47(1):113-21. PubMed ID: 16360724
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
    Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO
    Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor.
    von dem Borne PA; Cox LM; Bouma BN
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):251-7. PubMed ID: 16651866
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effect of vascular catheterisation on blood coagulation.
    Jacobsson B; Nilsson IM
    Acta Chir Scand; 1970; 136(5):369-74. PubMed ID: 5518333
    [No Abstract]   [Full Text] [Related]  

  • 75. Neurohumoral control of blood coagulation. 3. Prothrombin synthesis.
    Landaburu RH; Quintana CM; De Landaburu CA; Castellanos DE
    Acta Physiol Lat Am; 1971; 21(4):339-45. PubMed ID: 5147125
    [No Abstract]   [Full Text] [Related]  

  • 76. [Effect of small doses of heparin in a complex tatment of patients with pneumocarditis on the blood coagulation and fibrinolytic system].
    Aizenberg AA; Gritsiuk AI
    Sov Med; 1969 Feb; 32(2):33-9. PubMed ID: 5380421
    [No Abstract]   [Full Text] [Related]  

  • 77. Effect of Cerastes cerastes venom on blood coagulation mechanisms.
    Mohamed AH; el-Serougi M; Khaled LZ
    Toxicon; 1969 Nov; 7(3):181-4. PubMed ID: 5358062
    [No Abstract]   [Full Text] [Related]  

  • 78. [Disorders of the blood and cerebrospinal fluid coagulation and anticoagulation systems in experimental brain injury].
    Iurchenko VP
    Biull Eksp Biol Med; 1971 Oct; 72(10):30-2. PubMed ID: 5126147
    [No Abstract]   [Full Text] [Related]  

  • 79. [Antihemophilic globulin activity and other indices of the blood coagulant and anticoagulant system in acute pneumonia patients].
    Zhivoderov VM; Rychkova MA; Pin'kevich NM
    Ter Arkh; 1968 Nov; 40(11):39-42. PubMed ID: 5746740
    [No Abstract]   [Full Text] [Related]  

  • 80. [Effect of the antioxidant ionol on blood coagulation and fibrinolysis].
    Mishchenko VP; Gol'denberg IuM; Novosel'tseva TV
    Vopr Med Khim; 1980; 26(6):763-7. PubMed ID: 7456408
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.